(Reuters) -PerkinElmer Inc on Monday agreed to sell three of its businesses to private equity firm New Mountain Capital for up to $2.45 billion in cash, as it looks to focus on its life sciences and ...

PerkinElmer is slimming down to focus solely on diagnostics and life sciences research, selling off its other businesses in a deal that will hand it $2.3 billion in cash. The funding is expected to ...

On Tuesday, May 16, the name PerkinElmer and its PKI symbol disappeared from the stock market. In its place is a piece of the old company, branded as Revvity Inc. (NYSE:RVTY). PerkinElmer was formed ...

Forbes contributors publish independent expert analyses and insights. We write about stock options with a focus on yield. In general, dividend amounts are not always predictable and tend to follow the ...

PerkinElmer is acquiring Covaris, which manufactures applications and solutions for life science companies, as part of an effort to expand its life sciences portfolio. The biotech announced Monday ...

PerkinElmer said today it agreed to acquire BioLegend, a provider of life science antibodies and reagents, for approximately $5.25 billion in cash and stock—the largest acquisition in the buyer’s ...

The stock price of PerkinElmer Inc. (NYSE: PKI), a Waltham-based company focused on diagnostics, life sciences, and applied services markets, is up roughly 2x from the levels it was at on March 23, ...

WASHINGTON (Reuters) – Medical diagnostic firm PerkinElmer Inc faces a federal investigation into its role in an alleged Medicare fraud involving tens of thousands of unnecessary genetic cancer tests, ...

PerkinElmer, a global manufacturer with more than 500 employees in Shelton, is eliminating close to 75 jobs as it moves four product lines to England and Singapore. The company, headquartered in ...

SACRAMENTO (CBS13) — Following a CBS13 investigation into the state's COVID testing lab and its $1.7 billion contract with PerkinElmer, the company is now effectively suing a whistleblower who spoke ...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) today announced it has entered into an agreement to acquire BioLegend, a leading, global provider of life science ...